Beam, Inc. (BEAM) Tops Q1 EPS by 20c, provides outlook

Beam, Inc. (NASDAQ: BEAM) reported Q1 EPS of ($1.21), $0.20 better than the analyst estimate of ($1.41). Revenue for the quarter came in at $7.41 million versus the consensus estimate of $16.97 million.

Outlook:
Beam expects that its cash, cash equivalents and marketable securities as of March 31, 2024, will enable the company to fund its anticipated operating expenses and capital expenditure requirements into 2027.

For earnings history and earnings-related data on Beam, Inc. (BEAM) click here.

You May Also Be Interested In

• Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-304 for the Treatment of Phenylketonuria (PKU) by the United States (U.S.) Food and Drug Administration
• Wall Street scrambles to lift Micron price targets ahead of earnings
• Hyperscale Data launches $300M at-the-market stock offering